| Autor: |
Eriksson M; Department of Surgical Sciences, Section of Anesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden., Lipcsey M; Department of Surgical Sciences, Section of Anesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.; Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Ilboudo Y; Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada., Yoshiji S; Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Department of Human Genetics, McGill University, Montréal, Québec, Canada.; Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Richards B; Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.; Department of Twin Research, King's College London, London, United Kingdom.; 5 Prime Sciences, Montréal, Québec, Canada., Hultström M; Department of Surgical Sciences, Section of Anesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden.; Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.; Department of Medical Cell Biology, Integrative Physiology, Uppsala University, Uppsala, Sweden. |
| Abstrakt: |
The outcome for patients with sepsis-associated acute kidney injury in the intensive care unit (ICU) remains poor. Low serum uromodulin (sUMOD) protein levels have been proposed as a causal mediator of this effect. We investigated the effect of different levels of sUMOD on the risk of sepsis and severe pneumonia and outcomes in these conditions. A two-sample Mendelian randomization (MR) study was performed. Single-nucleotide polymorphisms (SNPs) associated with increased levels of sUMOD were identified and used as instrumental variables for association with outcomes. Data from different cohorts were combined based on disease severity and meta-analyzed. Five SNPs associated with increased sUMOD levels were identified and tested in six datasets from two biobanks. There was no protective effect of increased levels of sUMOD on the risk of sepsis [two cohorts, odds ratio (OR) 0.99 (95% confidence interval 0.95-1.03), P = 0.698, and OR 0.95 (0.91-1.00), P = 0.060, respectively], risk of sepsis requiring ICU admission [OR 1.04 (0.93-1.16), P = 0.467], ICU mortality in sepsis [OR 1.00 (0.74-1.37), P = 0.987], risk of pneumonia requiring ICU admission [OR 1.05 (0.98-1.14), P = 0.181], or ICU mortality in pneumonia [OR 1.17 (0.98-1.39), P = 0.079]. Meta-analysis of hospital-admitted and ICU-admitted patients separately yielded similar results [OR 0.98 (0.95-1.01), P = 0.23, and OR 1.05 (0.99-1.12), P = 0.86, respectively]. Among patients with sepsis and severe pneumonia, there was no protective effect of different levels of sUMOD. Results were consistent regardless of geographic origins and not modified by disease severity. NEW & NOTEWORTHY The presence of acute kidney injury in severe infections increases the likelihood of poor outcome severalfold. A decrease in serum uromodulin (sUMOD), synthetized in the kidney, has been proposed as a mediator of this effect. Using the Mendelian randomization technique, we tested the hypothesis that increased sUMOD is protective in severe infections. Analyses, however, showed no evidence of a protective effect of higher levels of sUMOD in sepsis or severe pneumonia. |
